Matches in SemOpenAlex for { <https://semopenalex.org/work/W4254152438> ?p ?o ?g. }
Showing items 1 to 82 of
82
with 100 items per page.
- W4254152438 endingPage "202" @default.
- W4254152438 startingPage "181" @default.
- W4254152438 abstract "The estrogen receptor α (ERα) has proven to be the single most important target in breast cancer over the last 30 years. The use of the selective ER modulator (SERM) tamoxifen for the treatment and prevention of breast cancer has changed therapeutics. The SERM raloxifene, approved for the treatment of osteoporosis, lacks tamoxifens increased risk for endometrial cancer and is being evaluated for the prevention of breast cancer. Other SERMs approved or under development for use against breast cancer or osteoporosis include toremifene, GW5638, GW7604 (the active metabolite of GW5638), idoxifene, lasofoxifene, arzoxifene, bazedoxifene, EM-800 and acolbifene (the active metabolite of EM- 800). Aromatase inhibitors (AIs) have recently proven to be more efficacious than tamoxifen as first-line therapy, efficacious for second-line therapy (e.g. against tamoxifen-resistant disease), and useful for extended adjuvant therapy after tamoxifen. The AIs include the non-steroidal agents letrozole and anastrole, and the steroidal agent exemestane. The pure antiestrogen fulvestrant has proven to be just as effective as AIs. Other pure antiestrogens, ZK-703, ZK-253, RU 58668 and TAS-108 show great promise. The development of resistance to endocrine therapy remains a clinically important problem, and laboratory models based on human breast cancer cells grown as tumors in immune-compromised mice have led to important insights into this problem. Progesterone receptor-negative status of ER-positive breast cancers may reflect altered growth factor receptor signaling, and helps to explain why this subclass of tumors exhibits lower response rates to tamoxifen compared to cancers typed progesterone receptor-positive. Crosstalk among plasma membrane-localized ER, growth factor receptor signaling, and nuclear-localized ER provide further insights into antihormonal-resistant breast cancer. Keywords: Estrogen receptor, selective estrogen receptor modulator, aromatase inhibitor, pure antiestrogen, breast cancer, antihormonal resistance" @default.
- W4254152438 created "2022-05-12" @default.
- W4254152438 creator A5027730481 @default.
- W4254152438 creator A5049919852 @default.
- W4254152438 creator A5053893712 @default.
- W4254152438 creator A5054260208 @default.
- W4254152438 date "2006-02-01" @default.
- W4254152438 modified "2023-10-16" @default.
- W4254152438 title "Estrogen Receptors as Therapeutic Targets in Breast Cancer" @default.
- W4254152438 doi "https://doi.org/10.2174/156802606776173483" @default.
- W4254152438 hasPublicationYear "2006" @default.
- W4254152438 type Work @default.
- W4254152438 citedByCount "211" @default.
- W4254152438 countsByYear W42541524382012 @default.
- W4254152438 countsByYear W42541524382013 @default.
- W4254152438 countsByYear W42541524382014 @default.
- W4254152438 countsByYear W42541524382015 @default.
- W4254152438 countsByYear W42541524382016 @default.
- W4254152438 countsByYear W42541524382017 @default.
- W4254152438 countsByYear W42541524382018 @default.
- W4254152438 countsByYear W42541524382019 @default.
- W4254152438 countsByYear W42541524382020 @default.
- W4254152438 countsByYear W42541524382021 @default.
- W4254152438 countsByYear W42541524382022 @default.
- W4254152438 countsByYear W42541524382023 @default.
- W4254152438 crossrefType "journal-article" @default.
- W4254152438 hasAuthorship W4254152438A5027730481 @default.
- W4254152438 hasAuthorship W4254152438A5049919852 @default.
- W4254152438 hasAuthorship W4254152438A5053893712 @default.
- W4254152438 hasAuthorship W4254152438A5054260208 @default.
- W4254152438 hasConcept C121608353 @default.
- W4254152438 hasConcept C126322002 @default.
- W4254152438 hasConcept C143998085 @default.
- W4254152438 hasConcept C2775860665 @default.
- W4254152438 hasConcept C2776067312 @default.
- W4254152438 hasConcept C2776166826 @default.
- W4254152438 hasConcept C2777176818 @default.
- W4254152438 hasConcept C2777637070 @default.
- W4254152438 hasConcept C2777944059 @default.
- W4254152438 hasConcept C2778812593 @default.
- W4254152438 hasConcept C2779889926 @default.
- W4254152438 hasConcept C2780482068 @default.
- W4254152438 hasConcept C502942594 @default.
- W4254152438 hasConcept C530470458 @default.
- W4254152438 hasConcept C71924100 @default.
- W4254152438 hasConcept C84606932 @default.
- W4254152438 hasConceptScore W4254152438C121608353 @default.
- W4254152438 hasConceptScore W4254152438C126322002 @default.
- W4254152438 hasConceptScore W4254152438C143998085 @default.
- W4254152438 hasConceptScore W4254152438C2775860665 @default.
- W4254152438 hasConceptScore W4254152438C2776067312 @default.
- W4254152438 hasConceptScore W4254152438C2776166826 @default.
- W4254152438 hasConceptScore W4254152438C2777176818 @default.
- W4254152438 hasConceptScore W4254152438C2777637070 @default.
- W4254152438 hasConceptScore W4254152438C2777944059 @default.
- W4254152438 hasConceptScore W4254152438C2778812593 @default.
- W4254152438 hasConceptScore W4254152438C2779889926 @default.
- W4254152438 hasConceptScore W4254152438C2780482068 @default.
- W4254152438 hasConceptScore W4254152438C502942594 @default.
- W4254152438 hasConceptScore W4254152438C530470458 @default.
- W4254152438 hasConceptScore W4254152438C71924100 @default.
- W4254152438 hasConceptScore W4254152438C84606932 @default.
- W4254152438 hasIssue "3" @default.
- W4254152438 hasLocation W42541524381 @default.
- W4254152438 hasOpenAccess W4254152438 @default.
- W4254152438 hasPrimaryLocation W42541524381 @default.
- W4254152438 hasRelatedWork W1972790692 @default.
- W4254152438 hasRelatedWork W1984873736 @default.
- W4254152438 hasRelatedWork W1985026304 @default.
- W4254152438 hasRelatedWork W2041361029 @default.
- W4254152438 hasRelatedWork W2048027227 @default.
- W4254152438 hasRelatedWork W2048813529 @default.
- W4254152438 hasRelatedWork W2078697431 @default.
- W4254152438 hasRelatedWork W2131184855 @default.
- W4254152438 hasRelatedWork W2897518628 @default.
- W4254152438 hasRelatedWork W4230114496 @default.
- W4254152438 hasVolume "6" @default.
- W4254152438 isParatext "false" @default.
- W4254152438 isRetracted "false" @default.
- W4254152438 workType "article" @default.